Compare ZLAB & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | HUN |
|---|---|---|
| Founded | 2013 | 1970 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2017 | 2005 |
| Metric | ZLAB | HUN |
|---|---|---|
| Price | $17.59 | $10.27 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 11 |
| Target Price | ★ $57.22 | $10.23 |
| AVG Volume (30 Days) | 827.4K | ★ 5.1M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 9.43% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $441,629,000.00 | ★ $5,780,000,000.00 |
| Revenue This Year | $30.20 | N/A |
| Revenue Next Year | $34.71 | $3.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 24.14 | N/A |
| 52 Week Low | $17.72 | $7.30 |
| 52 Week High | $44.34 | $19.57 |
| Indicator | ZLAB | HUN |
|---|---|---|
| Relative Strength Index (RSI) | 17.58 | 59.51 |
| Support Level | $19.40 | $9.72 |
| Resistance Level | $18.67 | $11.14 |
| Average True Range (ATR) | 0.50 | 0.54 |
| MACD | 0.07 | 0.05 |
| Stochastic Oscillator | 3.05 | 61.70 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.